Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer.

Using flow cytometry, ENT treatment appeared to reduce the frequency of CD4+ CD25+ FoxP3+ Tregs within the ascites, though this did not reach statistical significance (Figure 3 A,B).

also in 111,027 other papers